Trial no.:
|
PACTR202311673887516 |
Date of Approval:
|
28/11/2023 |
Trial Status:
|
Retrospective registration - This trial was registered after enrolment of the first participant |
|
TRIAL DESCRIPTION |
Public title
|
Haloperidol versus Dexmedetomidine as an Adjuvant to Ondansetrone in Postoperative Nausea and Vomiting in Laparoscopic Cholecystectomy |
Official scientific title |
Haloperidol versus Dexmedetomidine as an Adjuvant to Ondansetrone in Postoperative Nausea and Vomiting in Laparoscopic Cholecystectomy |
Brief summary describing the background
and objectives of the trial
|
Despite the progression of the new anti-vomiting techniques, Postoperative nausea and vomiting (PONV) is still one of the most common complications after general anaesthesia especially after laparoscopic surgeries in the immediate 24 postoperative hours. No single antiemetic drug has been provided to be a universal solution to PONV.
In this study we will compare between Dexmedetomidine vs low dose haloperidol as an adjuvant to ondansetron in reliefing postoperative nausea and vomiting after laparoscopic cholecystectomy.
|
Type of trial |
RCT |
Acronym (If the trial has an acronym then please provide) |
|
Disease(s) or condition(s) being studied |
Anaesthesia |
Sub-Disease(s) or condition(s) being studied |
|
Purpose of the trial |
Treatment: Drugs |
Anticipated trial start date |
01/05/2023 |
Actual trial start date |
01/05/2023 |
Anticipated date of last follow up |
21/12/2023 |
Actual Last follow-up date |
|
Anticipated target sample size (number of participants) |
75 |
Actual target sample size (number of participants) |
|
Recruitment status |
Completed |
Publication URL |
|
|